Physicians' Academy for Cardiovascular Education

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.

New ACC/AHA hypertension guidelines empasize risk assessment

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA

A coordinated effort to organise STEMI care improved treatment time and patient outcomes

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - James Jollis, MD - Chapel Hill, NC, USA

Positive lesson from a negative trial comparing peri-operative continuation or interruption of DOAC therapy

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA - David H. Birnie, MD - Ottawa, ON, Canada

Machine learning program predicts that drinking more coffee lowers risk of CVD and stroke

3' education - Nov. 13, 2017 - AHA 2017 - Anaheim, CA - Laura M Stevens - Aurora, CO, USA

Highly adhering to a plant-based diet is associated with a lower risk of developing HF

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - AHA 2017 - Anaheim, CA, USA

Sodium Bicarbonate and N-Acetylcysteine tested for the prevention of serious adverse outcomes

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - AHA 2017 - Anaheim, CA, USA

Good BP measurement depends more on appropriate technique than on absence of staff

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Karen Johnson - Memphis, TN, USA

Target for BP lowering differs between Europe and USA

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA

Restrictive transfusion is non-inferior to liberal approach during cardiac surgery

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - David Mazer - Toronto, Ont, Canada

Analogous to LDL-c, the lower the better also seems true for inflammation

3' education - Nov. 14, 2017 - Paul Ridker, Boston, MA, USA

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

New ACC/AHA Hypertension Guidelines: stress on accuracy BP measurement method and lifestyle changes ánd a new target

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Paul Whelton, MD (Tulane University, New Orleans, LA, USA

More insight into effects of treatment with PCSK9 inhibition from 5 new FOURIER analyses

3' education - Nov. 14, 2017 - Anaheim, CA, USA - Robert Giugliano - Boston, MA, USA

Robust benefits for CV and limb event risk in PAD patients on PCSK9 inhibition

3' education - Nov. 13, 2017 - AHA 2017 - Anaheim, CA - Marc Bonaca - Boston, MA, USA

Greater relative and absolute risk reduction in high-risk subgroup with previous MI treated with PCSK9 inhibition

3' education - Nov. 13, 2017 - AHA 2017 - Anaheim, CA - Marc Sabatine - Boston, MA, VS

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

AHA 2017 - Anaheim, CA, USA

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.
The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.

AHA 2017 The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.

New ACC/AHA hypertension guidelines empasize risk assessment

AHA 2017 - Anaheim, CA, VS

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA
Prof. Clyde Yancy summarizes the most important new recommendations, starting with a new definition of hypertension, the need for a risk conversation and implications for therapy.

AHA 2017 Prof. Clyde Yancy summarizes the most important new recommendations, starting with a new definition of hypertension, the need for a risk conversation and implications for therapy.

A coordinated effort to organise STEMI care improved treatment time and patient outcomes

AHA 2017 - Anaheim, CA, USA

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - James Jollis, MD - Chapel Hill, NC, USA
The STEMI-ACCELERATOR 2 program involved multiple types of health professionals in 12 cities across the USA, to develop a treatment plan for STEMI. The program led to a reduction in heart failures and in-house mortality and shorter stays.

AHA 2017 The STEMI-ACCELERATOR 2 program involved multiple types of health professionals in 12 cities across the USA, to develop a treatment plan for STEMI. The program led to a reduction in heart failures and in-house mortality and shorter stays.

Effect CETP inhibitor similar in vascular patients with or without diabetes

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Martin Landray (University of Oxford, Oxford, United Kingdom)

News - Nov. 21, 2017

AHA 2017 A REVEAL-analysis shows that diabetes status does not affect the effect of anacetrapib on serious coronary events, and that anacetrapib slightly lowers the risk of new onset diabetes.

PCSK9 inhibitor lowers CV risk in peripheral artery disease and in high-risk patients with previous MI

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Marc Bonaca and Marc Sabatine (Brigham and Women’s Hospital, Boston, MA, USA)

News - Nov. 21, 2017

AHA 2017 New FOURIER analyses show benefit of treatment with evolocumab both in patiënts with PAD, and clinical factors in high-risk post-MI patients can predict extra high risk.

Positive lesson from a negative trial comparing peri-operative continuation or interruption of DOAC therapy

AHA 2017 - Anaheim, CA, USA

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA - David H. Birnie, MD - Ottawa, ON, Canada
BRUISE-CONTROL 1 showed an 80% reduction in device pocket hematoma with warfarin continuation vs bridging around device surgery. BRUISE-CONTROL 2 evaluated peri-procedural continuation vs interruption of DOACs.

AHA 2017 BRUISE-CONTROL 1 showed an 80% reduction in device pocket hematoma with warfarin continuation vs bridging around device surgery. BRUISE-CONTROL 2 evaluated peri-procedural continuation vs interruption of DOACs.

Epicardial botulinum toxin injection for now does not lower burden of postoperative AF

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Nathan Waldron (Duke University Medical Center, Durham, NC, USA

News - Nov. 20, 2017

AHA 2017 Neurotoxin injection yielded numerically lower risk of POAF in TNT-POAF study, along with a shorter duration of first POAF episode, but the study may have been underpowered.

Greater absolute benefit of SGLT2 inhibitor in secondary vs primary prevention in T2DM

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Kenneth Mahaffey (Stanford Center for Clinical Research, Stanford, CA, USA)

News - Nov. 20, 2017

AHA 2017 Analysis of CANVAS program compared use of canagliflozin in primary or secondary prevention and found a greater benefit on CV, renal and death outcomes in those with existing CVD.

Machine learning program predicts that drinking more coffee lowers risk of CVD and stroke

AHA 2017 - Anaheim, CA, USA

3' education - Nov. 13, 2017 - AHA 2017 - Anaheim, CA - Laura M Stevens - Aurora, CO, USA
Laura Stevens presented her poster on using artificial intelligence to identify risk factors for CVD and stroke. The found association with coffee was validated with traditional analyses.

AHA 2017 Laura Stevens presented her poster on using artificial intelligence to identify risk factors for CVD and stroke. The found association with coffee was validated with traditional analyses.

Highly adhering to a plant-based diet is associated with a lower risk of developing HF

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - AHA 2017 - Anaheim, CA, USA
Kyla Lara presented a poster at the AHA on her research on the effect of various dietary patterns, based on Food Frequency Questionnaires, on the risk of developing heart failure.

AHA 2017 Kyla Lara presented a poster at the AHA on her research on the effect of various dietary patterns, based on Food Frequency Questionnaires, on the risk of developing heart failure.

Baseline risk of outcomes does not predict the treatment effect of GLP-1 receptor agonist

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Robert J. Mentz (Duke University, Durham, NC, USA)

News - Nov. 15, 2017

AHA 2017 An analysis of the EXSCEL trial examined whether risk at baseline predicted the effect of exenatide on mortality and MACE.

SGLT-2 inhibition reduces mortality and hospitalization for HF in patients with diabetes and PAD

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Subodh Verma (St Michael's Hospital, University of Toronto, Canada)

News - Nov. 15, 2017

AHA 2017 A sub-analysis of the EMPA-REG OUTCOME examined whether the benefits of empaglifozin are preserved in diabetic patients with and without PAD.

AHA 2017